États-Unis -
anglais -
NLM (National Library of Medicine)
vital e - repro- vitamin e, vitamin a, vitamin d injection, emulsion
stuart products, inc. - alpha-tocopherol, d- (unii: n9pr3490h9) (.alpha.-tocopherol, d- - unii:n9pr3490h9), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41) - alpha-tocopherol, d- 300 [iu] in 1 ml - indications: vital e–repro is a clear, sterile, non-aqueous solution of vitamins e, a, and d for use as a supplemental source of those fat-soluble vitamins in cattle, sheep, and swine. each ml provides vitamin e in its highest biologically-available form - d-alpha -tocopherol, the same form found in colostrum and milk. intramuscular or subcutaneous injections of vital e-repro offer an efficient and rapid method to increase status of the fat-soluble vitamins e, a, and d in animals. administration and dosage: intramuscular or subcutaneous administration only. suggested dosage: cattle (dairy and beef) cows and heifers 2 weeks pre-partum 8-10 ml sheep ewes 2 weeks pre-partum 3-4 ml swine gilts 2 weeks pre-breeding 4-5 ml 2 weeks pre-partum 4-5 ml sows 2 weeks pre-partum 5-6 ml at weaning 5-6 ml
États-Unis -
anglais -
NLM (National Library of Medicine)
pediatric infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
États-Unis -
anglais -
NLM (National Library of Medicine)
pediatric infuvite multiple vitamins for infusion- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride,
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 5 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
États-Unis -
anglais -
NLM (National Library of Medicine)
pediatric infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 80 mg in 4 ml - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
États-Unis -
anglais -
NLM (National Library of Medicine)
adult infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phos
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - ascorbic acid 200 mg in 10 ml - infuvite adult is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult is contraindicated in patients who have infuvite adult has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirements may exceed those of nonpregnant women. animal reproduction studies have not been conducted with infuvite adult. infuvite adult has not been studied in lactating women.lactating women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirement may exceed those of nonlactating women. caution should be exercised when infuvite adult is administered to a nursing mother. safety and effectiveness in children below the age of 11 years have not been establish
États-Unis -
anglais -
NLM (National Library of Medicine)
pediatric infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite pediatric is contraindicated in patients who have: infuvite pediatric has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for pregnancy because their vitamin requirements may exceed those of non-pregnant women. animal reproduction studies have not been conducted with infuvite pediatric (multiple vitamins injection). infuvite pediatric has not been studied in nursing mothers. lactating women may have vitamin requirements that exceed those of non-lactating women. caution should be exercised when infuvite pediatric is administered to nursing mothers. infuvite pediatric is approved for the prevention of vitamin deficiency in pediatric patients up to 11 years
États-Unis -
anglais -
NLM (National Library of Medicine)
adult infuvite multiple vitamins- ascorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, riboflavin-5 phos
sandoz inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii - infuvite adult is a combination of vitamins indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult is contraindicated in patients who have infuvite adult has not been studied in pregnant women. pregnant women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirements may exceed those of nonpregnant women. animal reproduction studies have not been conducted with infuvite adult. infuvite adult has not been studied in lactating women.lactating women should follow the u.s. recommended daily allowances for their condition, because their vitamin requirement may exceed those of nonlactating women. caution should be exercised when infuvite adult is administered to a nursing mother. safety and effectiveness in children below the age of 11 years have not been establish
Canada -
anglais -
Health Canada
vitamin a (100,000 iu) and vitamin e (20 iu) oral liquid preparation capsule
nutricorp international - vitamin a (retinyl palmitate); vitamin e (dl-alpha tocopheryl acetate) - capsule - 100000unit; 20unit - vitamin a (retinyl palmitate) 100000unit; vitamin e (dl-alpha tocopheryl acetate) 20unit - vitamin a
Canada -
anglais -
Health Canada
vitamin a (200,000 iu) and vitamin e (40 iu) oral liquid preparation capsule
nutricorp international - vitamin a (retinyl palmitate); vitamin e (dl-alpha tocopheryl acetate) - capsule - 200000unit; 40unit - vitamin a (retinyl palmitate) 200000unit; vitamin e (dl-alpha tocopheryl acetate) 40unit - vitamin a
États-Unis -
anglais -
NLM (National Library of Medicine)
adult infuvite multiple vitamins for infusion- asorbic acid, vitamin a palmitate, cholecalciferol, thiamine hydrochloride, ribof
sandoz canada inc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin a palmitate (unii: 1d1k0n0vvc) (vitamin a - unii:81g40h8b0t), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), thiamine hydrochloride (unii: m572600e5p) (thiamine - unii:x66nso3n35), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), d - ascorbic acid 200 mg in 10 ml - infuvite adult is indicated as a daily multivitamin maintenance supplement for adults and children aged 11 and older receiving parenteral nutrition. infuvite adult is also indicated in other situations where administration by the intravenous route is required. such situations include surgery, extensive burns, fractures and other trauma, severe infectious diseases, and comatose states, which may provoke a “stress” situation with profound alterations in the body’s metabolic demands and consequent tissue depletion of nutrients. the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy. infuvite adult (administered in intravenous fluids under proper dilution) contributes intake of necessary vitamins toward maintaining the body’s normal resistance and repair processes. patients with multiple vitamin deficiencies or with markedly increased requirements may be given multiples of the daily dosage for two or more days, as indicated by the clinical st